This provider's $14.4M in total Medicare payments ranks in the 93th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 136% from 2017 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 128% in 2018
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2017 | $119.86 | $93.79 | 1.28x | $26.07 | $941.1K | 5.3K | 3.7K |
| 2018 | $204.02 | $154.55 | 1.32x | $49.47 | $2.1M | 13.0K | 6.4K |
| 2019 | $204.79 | $153.14 | 1.34x | $51.65 | $2.2M | 13.6K | 7.6K |
| 2020 | $167.84 | $117.28 | 1.43x | $50.56 | $2.7M | 17.5K | 8.4K |
| 2021 | $178.28 | $125.39 | 1.42x | $52.89 | $2.3M | 16.2K | 8.4K |
| 2022 | $40.96 | $27.97 | 1.46x | $12.99 | $2.0M | 17.2K | 10.9K |
| 2023 | $44.14 | $31.66 | 1.39x | $12.48 | $2.2M | 23.5K | 17.8K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (an | 29.9K | $7.3M | $243.84 | 1.35x |
| G0482 | Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (an | 21.6K | $4.2M | $196.03 | 1.38x |
| 80307 | Testing for presence of drug | 24.9K | $1.6M | $64.94 | 1.54x |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 6.9K | $590.5K | $85.73 | 2.04x |
| G0480 | Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (an | 2.0K | $230.4K | $113.08 | 1.38x |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 718 | $110.9K | $154.44 | 1.35x |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 3.9K | $96.3K | $24.93 | 2.01x |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | 936 | $15.4K | $16.48 | 1.09x |
| 80053 | Blood test, comprehensive group of blood chemicals | 1.5K | $15.1K | $10.36 | 1.11x |
| 82670 | Measurement of total estradiol (hormone) | 454 | $12.4K | $27.36 | 1.09x |
| 84403 | Testosterone (hormone) level, total | 458 | $11.6K | $25.27 | 1.10x |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | 869 | $11.4K | $13.13 | 1.09x |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1.5K | $11.3K | $7.61 | 1.11x |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | 258 | $8.9K | $34.61 | 1.33x |
| 84402 | Testosterone (hormone) level, free | 357 | $8.9K | $24.89 | 1.11x |
| 82627 | Dehydroepiandrosterone (dhea-s) hormone level | 357 | $7.8K | $21.77 | 1.11x |
| 84146 | Prolactin (milk producing hormone) level | 378 | $7.2K | $18.98 | 1.11x |
| 87505 | Detection test by nucleic acid for digestive tract pathogen, multiple types or subtypes, 3-5 targets | 53 | $6.7K | $125.74 | 1.88x |
| 83036 | Hemoglobin a1c level | 699 | $6.7K | $9.53 | 1.09x |
| 83001 | Gonadotropin, follicle stimulating (reproductive hormone) level | 365 | $6.6K | $18.19 | 1.11x |
This provider submits charges 1.41 times higher than what Medicare actually pays.
A markup ratio of 1.41x means for every $100 Medicare pays, this provider initially charges $141. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in SC for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Vikor Scientific, Llc | Charleston, SC | $141.0M | ✓ Clear |
| Premier Medical, Inc. | Greenville, SC | $33.7M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data